Ethnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta-analysis

Francisco Cézar Aquino de MoraesAnna Luíza Soares de Oliveira RodriguesEric PasqualottoJéssica Fernanda CassemiroJhonny Limachi-ChoqueRommel Mário Rodríguez Burbano2026-03-222026-03-22202510.1007/s12094-024-03843-4https://doi.org/10.1007/s12094-024-03843-4https://andeanlibrary.org/handle/123456789/85853Citaciones: 1enMedicineInternal medicineLung cancerHazard ratioMeta-analysisOncologyConfidence intervalAdverse effectRelative riskAdenocarcinomaEthnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta-analysisreview